Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Shane Sopp

Gynecology Syracuse, NY Medical Doctor

NPI 1497741243 CMS profile 339622

4900 Broad Rd, Cgh Pob Suite 2V, Syracuse, NY 13215

Open in the dashboard

General payments

$84,130

232 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Shane Sopp of Syracuse, NY is reported in the CMS Open Payments database as having received $84,130 across 232 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $6,018 42
2020 General $16,782 79
2019 General $61,330 111

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shane Sopp
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Shane Sopp were reported at $0. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Shane Sopp Gynecology median Middle half National median
2019 $61,330 $199 $66–$472 $163
2020 $16,782 $114 $42–$287 $114
2021 $6,018 $141 $42–$430 $132
2022 $0 $173 $52–$532 $149
2023 $0 $170 $57–$501 $160
2024 $0 $157 $50–$424 $164
2025 $0 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. AbbVie, Inc. $38,766 56 payments
  2. Lupin Inc. $21,374 28 payments
  3. TherapeuticsMD, Inc. $17,217 33 payments
  4. Boston Scientific Corporation $3,733 20 payments
  5. Axonics Modulation Technologies, Inc. $1,517 29 payments
  6. Pfizer Inc. $388 17 payments
  7. Coloplast Corp $297 6 payments
  8. Astellas Pharma US Inc $237 11 payments
  9. Amgen Inc. $190 12 payments
  10. Medtronic USA, Inc. $94 3 payments
  11. Other $317 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $66,591 28 payments
  2. Travel and Lodging $9,300 19 payments
  3. Food and Beverage $6,213 181 payments
  4. Consulting Fee $1,516 1 payment
  5. Honoraria $473 1 payment
  6. Education $38 2 payments
Products named General payments · program years 2019–2021
  1. Orilissa Endocrinology $25,688 35 payments
  2. SOLOSEC Obstetricsgynecology $19,858 27 payments
  3. ORILISSA Womens Health $10,527 19 payments
  4. ANNOVERA $8,634 14 payments
  5. BIJUVA $6,424 8 payments
  6. SOLYX $2,950 3 payments
  7. ORIAHNN $2,700 12 payments
  8. IMVEXXY $2,105 8 payments
  9. SOLOSEC Obstetrics/Gynecology $1,516 1 payment
  10. Axonics r-SNM System $809 11 payments
  11. Other $3,597 135 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

232 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record